{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:59:02Z","timestamp":1792796342494,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T00:00:00Z","timestamp":1733270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG3M2011"],"award-info":[{"award-number":["CMRPG3M2011"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00109-024-02505-w","type":"journal-article","created":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T13:27:57Z","timestamp":1733318877000},"page":"101-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Molecular characterization of ovarian squamous cell carcinoma originating from mature teratoma"],"prefix":"10.1007","volume":"103","author":[{"given":"Angel","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chyong-Huey","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Shine","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Yun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huei-Jean","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-0874","authenticated-orcid":false,"given":"Ren-Chin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,4]]},"reference":[{"key":"2505_CR1","unstructured":"WHO Classification of Tumours Editorial Board. Female genital tumours. Lyon (France): International Agency for Research on Cancer (2020) (WHO classification of tumours series). http:\/\/publications.iarc.fr\/592. 5th ed2020"},{"key":"2505_CR2","first-page":"635","volume":"47","author":"U Surti","year":"1990","unstructured":"Surti U, Hoffner L, Chakravarti A, Ferrell RE (1990) Genetics and biology of human ovarian teratomas. I. Cytogenetic analysis and mechanism of origin. Am J Hum Genet 47:635\u2013643","journal-title":"Am J Hum Genet"},{"key":"2505_CR3","first-page":"644","volume":"47","author":"R Deka","year":"1990","unstructured":"Deka R, Chakravarti A, Surti U, Hauselman E, Reefer J, Majumder PP, Ferrell RE (1990) Genetics and biology of human ovarian teratomas. II. Molecular analysis of origin of nondisjunction and gene-centromere mapping of chromosome I markers. Am J Hum Genet 47:644\u2013655","journal-title":"Am J Hum Genet"},{"key":"2505_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1073\/pnas.63.3.699","volume":"63","author":"D Linder","year":"1969","unstructured":"Linder D (1969) Gene loss in human teratomas. Proc Natl Acad Sci U S A 63:699\u2013704","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2505_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1056\/NEJM197501092920202","volume":"292","author":"D Linder","year":"1975","unstructured":"Linder D, McCaw BK, Hecht F (1975) Parthenogenic origin of benign ovarian teratomas. N Engl J Med 292:63\u201366","journal-title":"N Engl J Med"},{"key":"2505_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1469-1809.1970.tb00216.x","volume":"34","author":"D Linder","year":"1970","unstructured":"Linder D, Power J (1970) Further evidence for post-meiotic origin of teratomas in the human female. Ann Hum Genet 34:21\u201330","journal-title":"Ann Hum Genet"},{"key":"2505_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/jmg.21.1.4","volume":"21","author":"JM Parrington","year":"1984","unstructured":"Parrington JM, West LF, Povey S (1984) The origin of ovarian teratomas. J Med Genet 21:4\u201312","journal-title":"J Med Genet"},{"key":"2505_CR8","first-page":"297","volume":"14","author":"SR Patil","year":"1978","unstructured":"Patil SR, Kaiser-McCaw B, Hecht F, Linder D, Lovrien EW (1978) Human benign ovarian teratomas: chromosomal and electrophoretic enzyme studies. Birth Defects Orig Artic Ser 14:297\u2013301","journal-title":"Birth Defects Orig Artic Ser"},{"key":"2505_CR9","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S1470-2045(08)70306-1","volume":"9","author":"A Hackethal","year":"2008","unstructured":"Hackethal A, Brueggmann D, Bohlmann MK, Franke FE, Tinneberg HR, Munstedt K (2008) Squamous-cell carcinoma in mature cystic teratoma of the ovary: systematic review and analysis of published data. Lancet Oncol 9:1173\u20131180","journal-title":"Lancet Oncol"},{"key":"2505_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ygyno.2006.12.008","volume":"105","author":"L Dos Santos","year":"2007","unstructured":"Dos Santos L, Mok E, Iasonos A, Park K, Soslow RA, Aghajanian C, Alektiar K, Barakat RR, Abu-Rustum NR (2007) Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecol Oncol 105:321\u2013324","journal-title":"Gynecol Oncol"},{"key":"2505_CR11","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0929-6646(08)60202-8","volume":"107","author":"RJ Chen","year":"2008","unstructured":"Chen RJ, Chen KY, Chang TC, Sheu BC, Chow SN, Huang SC (2008) Prognosis and treatment of squamous cell carcinoma from a mature cystic teratoma of the ovary. J Formos Med Assoc 107:857\u2013868","journal-title":"J Formos Med Assoc"},{"key":"2505_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12885-019-5393-y","volume":"19","author":"C Li","year":"2019","unstructured":"Li C, Zhang Q, Zhang S, Dong R, Sun C, Qiu C, Zhang Z, Yang X, Kong B (2019) Squamous cell carcinoma transformation in mature cystic teratoma of the ovary: a systematic review. BMC Cancer 19:217","journal-title":"BMC Cancer"},{"key":"2505_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/path.5799","volume":"256","author":"SH Jung","year":"2022","unstructured":"Jung SH, Park HC, Choi YJ, Song SY, Chung YJ, Lee SH (2022) Molecular genetic evidence supporting diverse histogenic origins of germ cell tumors. J Pathol 256:38\u201349","journal-title":"J Pathol"},{"key":"2505_CR14","doi-asserted-by":"crossref","unstructured":"Chao A, Huang HJ, Lin CY, Lee CH, Lin CH, Chao AS, Lai CH, Chang TC, Wu KY, Wu RC (2023) Hypoxia-associated genetic signature in ovarian steroid cell tumor NOS. Endocr Relat Cancer 30","DOI":"10.1530\/ERC-23-0179"},{"key":"2505_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12864-016-3425-4","volume":"18","author":"C Xu","year":"2017","unstructured":"Xu C, Nezami Ranjbar MR, Wu Z, DiCarlo J, Wang Y (2017) Detecting very low allele fraction variants using targeted DNA sequencing and a novel molecular barcode-aware variant caller. BMC Genomics 18:5","journal-title":"BMC Genomics"},{"key":"2505_CR16","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/REP-20-0422","volume":"161","author":"L Biswas","year":"2021","unstructured":"Biswas L, Tyc K, El Yakoubi W, Morgan K, Xing J, Schindler K (2021) Meiosis interrupted: the genetics of female infertility via meiotic failure. Reproduction 161:R13\u2013R35","journal-title":"Reproduction"},{"key":"2505_CR17","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1158\/1078-0432.CCR-17-1789","volume":"23","author":"SL Cooke","year":"2017","unstructured":"Cooke SL, Ennis D, Evers L, Dowson S, Chan MY, Paul J, Hirschowitz L, Glasspool RM, Singh N, Bell S, Day E, Kochman A, Wilkinson N, Beer P, Martin S, Millan D, Biankin AV, McNeish IA, Scottish Genomes P (2017) The driver Mutational Landscape of ovarian squamous cell carcinomas arising in mature cystic teratoma. Clin Cancer Res 23:7633\u20137640","journal-title":"Clin Cancer Res"},{"key":"2505_CR18","doi-asserted-by":"crossref","unstructured":"Ottaviano M, Giunta EF, Rescigno P, Pereira Mestre R, Marandino L, Tortora M, Riccio V, Parola S, Casula M, Paliogiannis P, Cossu A, Vogl UM, Bosso D, Rosanova M, Mazzola B, Daniele B, Palmieri G, Palmieri G (2021) The Enigmatic Role of TP53 in Germ Cell Tumours: Are We Missing Something? Int J Mol Sci 22","DOI":"10.3390\/ijms22137160"},{"key":"2505_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ygyno.2015.04.039","volume":"138","author":"BL Seagle","year":"2015","unstructured":"Seagle BL, Yang CP, Eng KH, Dandapani M, Odunsi-Akanji O, Goldberg GL, Odunsi K, Horwitz SB, Shahabi S (2015) TP53 hot spot mutations in ovarian cancer: selective resistance to microtubule stabilizers in vitro and differential survival outcomes from the Cancer Genome Atlas. Gynecol Oncol 138:159\u2013164","journal-title":"Gynecol Oncol"},{"key":"2505_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(21)00034-6","volume":"22","author":"HS Rugo","year":"2021","unstructured":"Rugo HS, Lerebours F, Ciruelos E, Drullinsky P, Ruiz-Borrego M, Neven P, Park YH, Prat A, Bachelot T, Juric D, Turner N, Sophos N, Zarate JP, Arce C, Shen YM, Turner S, Kanakamedala H, Hsu WC, Chia S (2021) Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4\/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study. Lancet Oncol 22:489\u2013498","journal-title":"Lancet Oncol"},{"key":"2505_CR21","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/S1470-2045(18)30905-7","volume":"20","author":"PA Konstantinopoulos","year":"2019","unstructured":"Konstantinopoulos PA, Barry WT, Birrer M, Westin SN, Cadoo KA, Shapiro GI, Mayer EL, O\u2019Cearbhaill RE, Coleman RL, Kochupurakkal B, Whalen C, Curtis J, Farooq S, Luo W, Eismann J, Buss MK, Aghajanian C, Mills GB, Palakurthi S, Kirschmeier P, Liu J, Cantley LC, Kaufmann SH, Swisher EM, D\u2019Andrea AD, Winer E, Wulf GM, Matulonis UA (2019) Olaparib and alpha-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial. Lancet Oncol 20:570\u2013580","journal-title":"Lancet Oncol"},{"key":"2505_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.it.2022.03.003","volume":"43","author":"P Spiliopoulou","year":"2022","unstructured":"Spiliopoulou P, Yang SYC, Bruce JP, Wang BX, Berman HK, Pugh TJ, Siu LL (2022) All is not lost: learning from 9p21 loss in cancer. Trends Immunol 43:379\u2013390","journal-title":"Trends Immunol"},{"key":"2505_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0090-8258(03)00259-2","volume":"90","author":"Y Mori","year":"2003","unstructured":"Mori Y, Nishii H, Takabe K, Shinozaki H, Matsumoto N, Suzuki K, Tanabe H, Watanabe A, Ochiai K, Tanaka T (2003) Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary. Gynecol Oncol 90:338\u2013341","journal-title":"Gynecol Oncol"},{"key":"2505_CR24","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.21873\/anticanres.13372","volume":"39","author":"A Gadducci","year":"2019","unstructured":"Gadducci A, Giuliani D, Cosio S, Lissoni A, Ferrero AM, Landoni F (2019) Clinical outcome of patients with malignant tumors Associated with mature cystic teratomas of the Ovary: a retrospective Multicenter Italian Study. Anticancer Res 39:2513\u20132517","journal-title":"Anticancer Res"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02505-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-024-02505-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-024-02505-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:51:31Z","timestamp":1737075091000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-024-02505-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,4]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2505"],"URL":"https:\/\/doi.org\/10.1007\/s00109-024-02505-w","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,4]]},"assertion":[{"value":"31 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The local institutional review board approved the study (IRB reference number: 202201239B0) and waived the requirement for informed consent due to the retrospective nature of the analysis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}